nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—Cold symptoms—Octreotide—thymus cancer	0.113	0.162	CcSEcCtD
Terazosin—Flu symptoms—Octreotide—thymus cancer	0.0816	0.117	CcSEcCtD
Terazosin—KCNH6—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0748	0.246	CbGpPWpGaD
Terazosin—KCNH7—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0666	0.219	CbGpPWpGaD
Terazosin—KCNH6—Potassium Channels—KCNA4—thymus cancer	0.0384	0.126	CbGpPWpGaD
Terazosin—KCNH7—Potassium Channels—KCNA4—thymus cancer	0.0342	0.112	CbGpPWpGaD
Terazosin—Loss of libido—Octreotide—thymus cancer	0.0306	0.044	CcSEcCtD
Terazosin—KCNH2—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0282	0.0927	CbGpPWpGaD
Terazosin—KCNH6—Neuronal System—KCNA4—thymus cancer	0.0167	0.055	CbGpPWpGaD
Terazosin—Arthropathy—Octreotide—thymus cancer	0.0156	0.0224	CcSEcCtD
Terazosin—KCNH7—Neuronal System—KCNA4—thymus cancer	0.0149	0.0491	CbGpPWpGaD
Terazosin—KCNH2—Potassium Channels—KCNA4—thymus cancer	0.0145	0.0476	CbGpPWpGaD
Terazosin—Nasal congestion—Octreotide—thymus cancer	0.0113	0.0162	CcSEcCtD
Terazosin—Anaphylactoid reaction—Octreotide—thymus cancer	0.0106	0.0153	CcSEcCtD
Terazosin—Arthritis—Octreotide—thymus cancer	0.0106	0.0152	CcSEcCtD
Terazosin—Pain in extremity—Octreotide—thymus cancer	0.0103	0.0148	CcSEcCtD
Terazosin—Osteoarthritis—Octreotide—thymus cancer	0.0103	0.0148	CcSEcCtD
Terazosin—Nasopharyngitis—Octreotide—thymus cancer	0.00918	0.0132	CcSEcCtD
Terazosin—Gastritis—Octreotide—thymus cancer	0.00909	0.0131	CcSEcCtD
Terazosin—Influenza—Octreotide—thymus cancer	0.00888	0.0128	CcSEcCtD
Terazosin—Asthma—Octreotide—thymus cancer	0.00888	0.0128	CcSEcCtD
Terazosin—Bronchitis—Octreotide—thymus cancer	0.00854	0.0123	CcSEcCtD
Terazosin—Dysuria—Octreotide—thymus cancer	0.0083	0.0119	CcSEcCtD
Terazosin—Pollakiuria—Octreotide—thymus cancer	0.0082	0.0118	CcSEcCtD
Terazosin—Weight increased—Octreotide—thymus cancer	0.00808	0.0116	CcSEcCtD
Terazosin—Depression—Octreotide—thymus cancer	0.00789	0.0113	CcSEcCtD
Terazosin—Jaundice—Octreotide—thymus cancer	0.00771	0.0111	CcSEcCtD
Terazosin—Urinary tract infection—Octreotide—thymus cancer	0.00769	0.0111	CcSEcCtD
Terazosin—Conjunctivitis—Octreotide—thymus cancer	0.00769	0.0111	CcSEcCtD
Terazosin—Epistaxis—Octreotide—thymus cancer	0.00746	0.0107	CcSEcCtD
Terazosin—Sinusitis—Octreotide—thymus cancer	0.00742	0.0107	CcSEcCtD
Terazosin—Rhinitis—Octreotide—thymus cancer	0.00712	0.0102	CcSEcCtD
Terazosin—Pharyngitis—Octreotide—thymus cancer	0.00705	0.0101	CcSEcCtD
Terazosin—Oedema peripheral—Octreotide—thymus cancer	0.007	0.0101	CcSEcCtD
Terazosin—Visual impairment—Octreotide—thymus cancer	0.00685	0.00984	CcSEcCtD
Terazosin—Tinnitus—Octreotide—thymus cancer	0.00662	0.00952	CcSEcCtD
Terazosin—Arrhythmia—Octreotide—thymus cancer	0.00635	0.00912	CcSEcCtD
Terazosin—KCNH2—Neuronal System—KCNA4—thymus cancer	0.00632	0.0208	CbGpPWpGaD
Terazosin—Malnutrition—Octreotide—thymus cancer	0.00618	0.00889	CcSEcCtD
Terazosin—Flatulence—Octreotide—thymus cancer	0.00609	0.00876	CcSEcCtD
Terazosin—Tension—Octreotide—thymus cancer	0.00607	0.00872	CcSEcCtD
Terazosin—Nervousness—Octreotide—thymus cancer	0.00601	0.00863	CcSEcCtD
Terazosin—Back pain—Octreotide—thymus cancer	0.00598	0.0086	CcSEcCtD
Terazosin—Vision blurred—Octreotide—thymus cancer	0.00583	0.00838	CcSEcCtD
Terazosin—Tremor—Octreotide—thymus cancer	0.00579	0.00833	CcSEcCtD
Terazosin—Ill-defined disorder—Octreotide—thymus cancer	0.00574	0.00825	CcSEcCtD
Terazosin—Malaise—Octreotide—thymus cancer	0.00558	0.00802	CcSEcCtD
Terazosin—Vertigo—Octreotide—thymus cancer	0.00556	0.00799	CcSEcCtD
Terazosin—Syncope—Octreotide—thymus cancer	0.00555	0.00797	CcSEcCtD
Terazosin—Palpitations—Octreotide—thymus cancer	0.00546	0.00786	CcSEcCtD
Terazosin—Loss of consciousness—Octreotide—thymus cancer	0.00544	0.00781	CcSEcCtD
Terazosin—Cough—Octreotide—thymus cancer	0.0054	0.00776	CcSEcCtD
Terazosin—Convulsion—Octreotide—thymus cancer	0.00536	0.0077	CcSEcCtD
Terazosin—Myalgia—Octreotide—thymus cancer	0.00526	0.00757	CcSEcCtD
Terazosin—Arthralgia—Octreotide—thymus cancer	0.00526	0.00757	CcSEcCtD
Terazosin—Chest pain—Octreotide—thymus cancer	0.00526	0.00757	CcSEcCtD
Terazosin—Anxiety—Octreotide—thymus cancer	0.00525	0.00754	CcSEcCtD
Terazosin—Discomfort—Octreotide—thymus cancer	0.0052	0.00748	CcSEcCtD
Terazosin—Dry mouth—Octreotide—thymus cancer	0.00515	0.0074	CcSEcCtD
Terazosin—Anaphylactic shock—Octreotide—thymus cancer	0.00505	0.00725	CcSEcCtD
Terazosin—Oedema—Octreotide—thymus cancer	0.00505	0.00725	CcSEcCtD
Terazosin—Shock—Octreotide—thymus cancer	0.00497	0.00714	CcSEcCtD
Terazosin—Thrombocytopenia—Octreotide—thymus cancer	0.00494	0.0071	CcSEcCtD
Terazosin—Tachycardia—Octreotide—thymus cancer	0.00493	0.00708	CcSEcCtD
Terazosin—Hyperhidrosis—Octreotide—thymus cancer	0.00488	0.00701	CcSEcCtD
Terazosin—Anorexia—Octreotide—thymus cancer	0.00481	0.00692	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0046	0.00661	CcSEcCtD
Terazosin—Insomnia—Octreotide—thymus cancer	0.00456	0.00656	CcSEcCtD
Terazosin—Paraesthesia—Octreotide—thymus cancer	0.00453	0.00651	CcSEcCtD
Terazosin—Dyspnoea—Octreotide—thymus cancer	0.0045	0.00647	CcSEcCtD
Terazosin—Somnolence—Octreotide—thymus cancer	0.00449	0.00645	CcSEcCtD
Terazosin—Dyspepsia—Octreotide—thymus cancer	0.00444	0.00639	CcSEcCtD
Terazosin—Decreased appetite—Octreotide—thymus cancer	0.00439	0.00631	CcSEcCtD
Terazosin—Fatigue—Octreotide—thymus cancer	0.00435	0.00625	CcSEcCtD
Terazosin—Pain—Octreotide—thymus cancer	0.00432	0.0062	CcSEcCtD
Terazosin—Constipation—Octreotide—thymus cancer	0.00432	0.0062	CcSEcCtD
Terazosin—Feeling abnormal—Octreotide—thymus cancer	0.00416	0.00598	CcSEcCtD
Terazosin—Gastrointestinal pain—Octreotide—thymus cancer	0.00413	0.00593	CcSEcCtD
Terazosin—Abdominal pain—Octreotide—thymus cancer	0.00399	0.00573	CcSEcCtD
Terazosin—Body temperature increased—Octreotide—thymus cancer	0.00399	0.00573	CcSEcCtD
Terazosin—Hypersensitivity—Octreotide—thymus cancer	0.00372	0.00534	CcSEcCtD
Terazosin—Asthenia—Octreotide—thymus cancer	0.00362	0.0052	CcSEcCtD
Terazosin—Pruritus—Octreotide—thymus cancer	0.00357	0.00513	CcSEcCtD
Terazosin—Diarrhoea—Octreotide—thymus cancer	0.00345	0.00496	CcSEcCtD
Terazosin—Dizziness—Octreotide—thymus cancer	0.00334	0.0048	CcSEcCtD
Terazosin—Vomiting—Octreotide—thymus cancer	0.00321	0.00461	CcSEcCtD
Terazosin—Rash—Octreotide—thymus cancer	0.00318	0.00457	CcSEcCtD
Terazosin—Dermatitis—Octreotide—thymus cancer	0.00318	0.00457	CcSEcCtD
Terazosin—Headache—Octreotide—thymus cancer	0.00316	0.00454	CcSEcCtD
Terazosin—Nausea—Octreotide—thymus cancer	0.003	0.00431	CcSEcCtD
Terazosin—KCNH7—Circadian rythm related genes—TP53—thymus cancer	0.00119	0.00391	CbGpPWpGaD
Terazosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	0.00118	0.00387	CbGpPWpGaD
Terazosin—ADRA1B—AMPK Signaling—TP53—thymus cancer	0.000708	0.00233	CbGpPWpGaD
Terazosin—ADRA1B—LPA receptor mediated events—AKT1—thymus cancer	0.000635	0.00209	CbGpPWpGaD
Terazosin—ADRA1A—AMPK Signaling—TP53—thymus cancer	0.000629	0.00207	CbGpPWpGaD
Terazosin—ADRA1B—AMPK Signaling—AKT1—thymus cancer	0.000598	0.00197	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL2—thymus cancer	0.000565	0.00186	CbGpPWpGaD
Terazosin—ADRA1A—AMPK Signaling—AKT1—thymus cancer	0.000531	0.00175	CbGpPWpGaD
Terazosin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000354	0.00116	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAML2—thymus cancer	0.000282	0.000926	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAML2—thymus cancer	0.000234	0.000768	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAML2—thymus cancer	0.000208	0.000682	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000179	0.000588	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2—thymus cancer	0.000171	0.000561	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2—thymus cancer	0.000155	0.000509	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000151	0.000497	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2—thymus cancer	0.000142	0.000465	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KIT—thymus cancer	0.00013	0.000427	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2—thymus cancer	0.000129	0.000423	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2—thymus cancer	0.000126	0.000413	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2—thymus cancer	0.000114	0.000375	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KIT—thymus cancer	0.000108	0.000355	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KIT—thymus cancer	9.59e-05	0.000315	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT1—thymus cancer	9.25e-05	0.000304	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2—thymus cancer	9.15e-05	0.000301	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT1—thymus cancer	8.4e-05	0.000276	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT1—thymus cancer	7.68e-05	0.000252	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2—thymus cancer	7.6e-05	0.00025	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT1—thymus cancer	6.97e-05	0.000229	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT1—thymus cancer	6.82e-05	0.000224	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2—thymus cancer	6.75e-05	0.000222	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT1—thymus cancer	6.19e-05	0.000204	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—thymus cancer	5.88e-05	0.000193	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT1—thymus cancer	4.96e-05	0.000163	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—thymus cancer	4.88e-05	0.00016	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—thymus cancer	4.33e-05	0.000142	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT1—thymus cancer	4.12e-05	0.000135	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT1—thymus cancer	3.66e-05	0.00012	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKT1—thymus cancer	2.81e-05	9.24e-05	CbGpPWpGaD
